Bruce A Perkins, MD

Clinician Scientist, Toronto General Hospital Research Institute (TGHRI)

 
Keywords: diabetes, diabetic nephropathy, clinical trials, telemedicine, renal function

Dr. Bruce Perkins is Professor of Medicine at the Division of Endocrinology and Metabolism, and the Institute of Health Policy, Management and Evaluation, University of Toronto. He obtained his MD and Internal Medicine training at the University of Toronto, his endocrinology subspecialty training at Harvard University, his Masters of Public Health in Epidemiology at the Harvard School of Public Health, and a research fellowship in epidemiology at the Joslin Diabetes Center.

He serves as a member of the Steering Committee and Chair, Microvascular Complications on Diabetes Canada’s Clinical Practice Guidelines Committee, leads the CIHR/SPOR-funded Diabetes Action Canada Clinical Trials Goal Group, and was the recipient of the Canadian Diabetes Association – Canadian Institutes of Health Research 2015 Young Scientist Award.

My research program focuses on clinical studies on diabetes complications (primarily on kidney disease and nerve disease complications of diabetes) as well as interventions to help with blood sugar control, including automated insulin delivery ("artificial pancreas") and adjunct-to-insulin approaches (medications used to help the way in which insulin works in the treatment of diabetes).

For a list of Dr. Perkins’s publications, please visit PubMed, Scopus, or Publons.
Clinician Scientist, Toronto General Hospital Research Institute (TGHRI)
Professor, Department of Medicine, University of Toronto
Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Staff Endocrinologist, Mount Sinai Hospital and University Health Network